Serán BioScience can expedite your entry into Phase I and Phase II, potentially saving your program significant time and investment. Our formulations are designed to be advanced right from the start. Our team addresses these time and material constraints during the formulation development process and takes a patient-centric approach to dosage form design that can shave years and expense off clinical stage programs. To learn more about Seran's flexible approach to formulation development, connect with us today. https://hubs.li/Q02vsk8C0 #efficient #drugdevelopment #innovation #cdmo
Serán BioScience
Biotechnology
Bend, Oregon 3,117 followers
There's a Science to Success.
About us
At Serán, Our mission is to provide optimized drug development and manufacturing services for our clients, from discovery to the clinic. Our science-driven approach utilizes predictive design tools, novel chemistry, analytical tools, enabling delivery technologies, and a thorough knowledge of quality and regulatory requirements to guide our customers on their clinical development path. Serán’s team are experts in delivery of poorly soluble compounds. Serán employs a range of novel technologies and pharmaceutical manufacturing operations to overcome drug development challenges for both small and large molecules, including complex granulations, spray-dried dispersions, hot melt extrudates, IR and MR tablet technologies, multiparticulates, and engineered particles inhalation. Our custom-built spray driers enable a wide variety of particle formation, from nano-structures to micro-particulates. Our particle engineering approaches are combined with our broad expertise in solid dosage forms resulting in the optimum clinical trial materials for your drug, including suspensions, capsules, and tablets.
- Website
-
http://www.seranbio.com
External link for Serán BioScience
- Industry
- Biotechnology
- Company size
- 201-500 employees
- Headquarters
- Bend, Oregon
- Type
- Privately Held
- Founded
- 2016
- Specialties
- CDMO, Drug Product, Formulation Development, cGMP Clinical Manufacturing, Hot Melt Extrusion, Spray Drying, Solubility Enhancement, Enhanced Bioavailability, Multiparticulates, Solid Dosage Forms, Inhalable Particulates, Process Engineering, Particle Engineering, Nanoparticle Formulations, and Packaging and Labeling
Locations
-
Primary
Get directions
63040 Lower Meadow Dr
Suite 110
Bend, Oregon 97701, US
Employees at Serán BioScience
Updates
-
In this inaugural Fierce Pharma event, Serán BioScience President & CEO, Dan Smithey, PhD, will present his thoughts on the importance of a streamlined approach to drug delivery and technology application in an today's evolving marketplace. Register for free and learn more here: https://hubs.li/Q02x9zyD0 #drugdelivery #drugdevelopment #fiercepharma
-
-
Serán BioScience will be presenting at and sponsoring this year's Global Drug Bioavailability Enhancement Summit. Connect with us to arrange a time to meet. Erica Schlesinger will be giving a talk on "Strategies for ASD Formulation Development". Serán is invested in substantial expansion of our manufacturing facilities and many new technologies. Come by our table to learn more!
In just 6 weeks time, the dual Summits return to Princeton and we would love to have you join us. Benefit from 25+ expert sessions and learn many new product development strategies, formulation approaches, delivery technologies in just 2 days. 2024’s Summit themes include: - High Dose Subcutaneous Delivery: Roadmap from Pre-clinical to Launch - How To Accelerate Drug Product Optimization: Integrated Program Delivery - - Using Translational Pharmaceutics - Percolation Behavior in an Immediate Release Tablet Dosage Form - Long-Acting Implant Product Development - The competences and Intricacies of Fluid Bed Technologies - Formulation of LAI: Understanding what Attributes Control Injectibility - The Impact of Excipient Selection on Modified Release Profiles - Co-Excipient Strategies for Controlled Release Formulations - Oral Delivery of Peptides: Challenges and Opportunities - Advancing Oral Modified Delivery for Rare Diseases via Lipid Based formulations - Streamlining SC Biologics Drug Development - Using PBPK Modeling for Risk Assessment in Drug Product Development - Efficient New Tools for Solubility Enhancement and Lifecycle Management - High Dose Subcutaneous Delivery: Roadmap from Pre-clinical to Launch - Translational Formulation Approaches for the Oral Delivery of eRo5/bRo5 - Molecules - Strategies for ASD Formulation Development - Leveraging Melt-Spray-Congeal Microspheres as a Versatile, Patient-centric Oral Multiparticulate Platform - Cellular Model of the Oral Lymphatic Absorption Pathway - Topical Ophthalmic Drug Delivery: Insights from Marketed Products - And much more. Speakers include Merck, Sanofi, Pfizer, Genentech, AbbVie, The Lubrizol Corporation, Glatt Group, Quotient Sciences, Bristol Myers Squibb, Serán BioScience, Novartis and many more. Planning to attend? Save 15% on your ticket with promo code LISPKR15. Full Summit details here: https://lnkd.in/gJ7zC938
-
-
In Part One of Serán BioScience's two-part video series, Dr. Wesley Tatum covers key considerations for ASD product development. Formulation development of ASDs focuses on polymer selection, the ratio of drug to polymer, and the design of the ASD particles to develop a system that is physically stable while also demonstrating optimal performance. In this presentation, Dr. Tatum will cover some of the philosophies and principles used to guide ASD product formulation. Learn more and watch on-demand here: https://hubs.li/Q02vsfcK0 #amorphousdispersion #ASD #drugdevelopment
-
You have a couple of opportunities to connect with Serán BioScience’s Erica Schlesinger at the upcoming NBC event in San Francisco. Connect with Erica direct for questions or to schedule a meeting.
Are you in San Francisco for NBC this week? Are you interested in Global Health? Whether your day job has a global health focus or you’re not, if you’re interested in how we as professionals and academics in the pharmaceutical industry are impacting the unmet needs of the global community, please consider joining the AAPS Global Health Community to engage. We’ll have two opportunities to connect at the upcoming NBC event in San Francisco. Please join us for an informal meet & greet on Tuesday, May 14 from 11:00-11:30 am in the F&B Seating Area in the Solutions center, next to Poster Forum 1 or for Happy Hour upstairs at the Owl Tree (601 Post St, San Francisco, CA 94109) on Wednesday at 4:30pm. Any questions? Contact me on Linked-In!
-
When choosing a CDMO, the stakes could not be higher. It's important to consider not only the capabilities and technical expertise that align with your project, there must be aligned values, and a shared commitment to open communication and partnership. Right from the start, Serán BioScience's teams are carefully considering your molecule profile, target patient profile and business goals when developing a project plan. Whether you're dealing with solubility or permeability concerns or you have limited material available, our teams will leverage their experience and expertise to develop an appropriate formulation strategy to meet your program's unique needs. Find out how Serán BioScience can support your program, right from the start! https://hubs.li/Q02vs8lS0 #CDMO #Partnership #drugformulation
-
-
Serán BioScience specializes in developing versatile solid dosage forms including capsules, tablets, and powder-in-bottle formulations, and a wide variety of other engineered solutions tailored for optimal in vivo exposure and scalability from discovery to clinical trials. Serán provides capsules, tablets, multi-particulates, and powder-in-bottle formulations. Our solid dosage forms are engineered for a wide range of formulation approaches such as overcoming solubility challenges and to enable extended-release. We complement industry-best production practices with the finest manufacturing equipment available to produce dosage forms that perform predictably and reliably. Connect with us to learn how Serán's experienced dosage form team can help bring your drug to market quickly and reliably. https://hubs.li/Q02vsbk80 #tabletdesign #cdmo #clinicaltrial #dosageform
-
Meet Serán BioScience”s very own Erica Schlesinger at NBC!
Are you here at NBC? Consider joining the AAPS Global Health Community for happy hour today at 4:30pm just down the street at the Owl Tree! Are you interested in Global Health? Whether your day job has a global health focus or you’re not, if you’re interested in how we as professionals and academics in the pharmaceutical industry are impacting the unmet needs of the global community, please consider joining the AAPS Global Health Community to engage. We’ll have two opportunities to connect at the upcoming NBC event in San Francisco. Please join us for an informal meet & greet on Tuesday, May 14 from 11:00-11:30 am in the F&B Seating Area in the Solutions center, next to Poster Forum 1 or for Happy Hour upstairs at the Owl Tree (601 Post St, San Francisco, CA 94109) on Wednesday at 4:30pm. Any questions? Contact me on Linked-In!
-
Serán BioScience is a leading science-based CDMO that specializes in a variety of drug delivery and formulation approaches suited to optimizing bioavailability. Serán’s experienced formulation team works with customers to identify an appropriate technology and formulation strategy to meet each program’s unique needs with a material-sparing approach. For early discovery and toxicology studies, our scientists utilize a variety of suspension and solution approaches to obtain desired in vivo exposure, especially at high doses. As programs advance to the clinic, Serán's solid dosage form approaches are designed to achieve preferred performance and are engineered for scalability. Learn how Serán's approach to formulation development can gain your molecule the competitive edge. https://hubs.li/Q02vs9zx0 #drugformulation #cdmo #drugdevelopment
-
-
CPHI NA starts tomorrow! Leverage Serán BioScience's experienced scientists to solve your bioavailability challenges. Whether considering enabling technologies (amorphous solid dispersions, lipid formulations, particle size reduction techniques) or conventional approaches, we aim to deliver you the simplest approach that meets your program’s needs. Meet with us at CPHI NA Booth #701 to learn more about Serán's enabling technologies to enhance your molecule's performance. https://hubs.li/Q02vs7j90 #drugdevelopment #formulationdevelopment #spraydrying #CDMO
-